Re: An Insurer's Program to Incentivize Generic Oncology Drugs Did Not Alter Treatment Patterns or Spending on Care

Resnick Matthew J.

首页> 外文期刊>The Journal of Urology >Re: An Insurer's Program to Incentivize Generic Oncology Drugs Did Not Alter Treatment Patterns or Spending on Care

【24h】

Re: An Insurer's Program to Incentivize Generic Oncology Drugs Did Not Alter Treatment Patterns or Spending on Care

机译：RE：保险公司的激励易肿瘤药物的计划没有改变治疗模式或支出护理

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of Urology》 |2019年第6期|共1页
作者
Resnick Matthew J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Re: An Insurer's Program to Incentivize Generic Oncology Drugs Did Not Alter Treatment Patterns or Spending on Care [J] . Resnick Matthew J. The Journal of Urology . 2019,第6期

机译：RE：保险公司的激励易肿瘤药物的计划没有改变治疗模式或支出护理
2. European Society for Medical Oncology (ESMO) Program for the integration of oncology and Palliative Care: a 5-year review of the Designated Centers' incentive program. [J] . Cherny N, Catane R, Schrijvers Annals of oncology: official journal of the European Society for Medical Oncology . 2010,第2期

机译：欧洲肿瘤内科协会（ESMO）的肿瘤与姑息治疗相结合的计划：对指定中心的奖励计划进行了为期5年的审查。
3. European Society for Medical Oncology (ESMO) Program for the Integration of Oncology and Palliative Care: a 5-year reviewn of the Designated Centers' incentive program [J] . F. Strasser Annals of Oncology . 2010,第2期

机译：欧洲肿瘤内科协会（ESMO）肿瘤与姑息治疗相结合的计划：指定中心的奖励计划为期5年的回顾
4. Study of Effectiveness of Treatment by Nanolime of the Altered Calcarenite Stones of the Archeological Site of Volubilis Site (Morocco) [C] . Dalai Badreddine, Kevin Beck, Xavier Brunetaud, International conference on progress in cultural heritage preservation . 2018

机译：用纳米石灰处理Volubilis遗址（摩洛哥）考古遗址的钙钙石蚀变石的有效性研究
5. How government policies, patents, and market incentives affect originator and generic pharmaceutical firm behavior towards generic drug entry. [D] . Rhee, Jinnie. 2007

机译：政府政策，专利和市场激励措施如何影响发起人和仿制药公司对仿制药进入的行为。
6. Impacts of Generic Competition and Benefit Management Practices on Spending for Prescription Drugs: Evidence from Medicare’s Part D Benefit [O] . Steven Sheingold, Nguyen Xuan Nguyen 2014

机译：通用竞争和收益管理做法对处方药支出的影响：Medicare D部分收益的证据
7. UT3 Firm- and Drug-Specific Patterns of Generic Drug Prices Experienced by United States Medicaid Programs: 1991-2008 [O] . Berry E.A., Kelton C.M., Yu Y., 2012

机译：美国医疗补助计划经历过的UT3公司和药品特定的通用药品价格模式：1991-2008年
8. Effects of Using Generic Drugs on Medicare's Prescription Drug Spending. A CBO Study [R] . 2010

机译：使用仿制药对医疗保险处方药消费的影响。一项CBO研究

Re: An Insurer's Program to Incentivize Generic Oncology Drugs Did Not Alter Treatment Patterns or Spending on Care

著录项

相似文献

相关主题

期刊订阅